MG
ALDX icon

Michael Gelband’s Aldeyra Therapeutics ALDX Stock Holding History

Michael Gelband’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-167,604
Closed -$283K – 1532
2026
Q1 		$283K Buy
167,604
+75,214
+81% +$330K ﹤0.01% 1321
2025
Q4 		$479K Buy
92,390
+77,439
+518% +$398K ﹤0.01% 1195
2025
Q3 		$78K Buy
+14,951
New +$78K ﹤0.01% 1442
2024
Q1 		– Sell
-21,560
Closed -$76K – 1455
2023
Q4 		$76K Sell
21,560
-39,089
-64% -$121K ﹤0.01% 1370
2023
Q3 		$405K Buy
+60,649
New +$450K ﹤0.01% 1311
2023
Q2 		– Sell
-13,800
Closed -$137K – 1817
2023
Q1 		$137K Buy
+13,800
New +$97.5K ﹤0.01% 1608
2022
Q4 		– Sell
-33,685
Closed -$180K – 1602
2022
Q3 		$180K Buy
33,685
+11,190
+50% +$67.1K ﹤0.01% 1666
2022
Q2 		$90K Buy
22,495
+2,364
+12% +$8.13K ﹤0.01% 1752
2022
Q1 		$89K Sell
20,131
-4,900
-20% -$19.5K ﹤0.01% 2013
2021
Q4 		$100K Sell
25,031
-5,463
-18% -$41.7K ﹤0.01% 1950
2021
Q3 		$268K Buy
+30,494
New +$280K ﹤0.01% 1660
2021
Q2 		– Sell
-156,414
Closed -$1.86M – 2288
2021
Q1 		$1.86M Buy
156,414
+16,894
+12% +$195K 0.03% 595
2020
Q4 		$957K Buy
139,520
+128,098
+1,122% +$899K 0.01% 879
2020
Q3 		$85K Sell
11,422
-1,663
-13% -$10.7K ﹤0.01% 1607
2020
Q2 		$55K Buy
+13,085
New +$47.8K ﹤0.01% 1680

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Michael Gelband's ALDX Position: Q2 2026 in Review

Michael Gelband sold out of Aldeyra Therapeutics (ALDX) in Q2 2026, closing a stake of 167,604 shares — an estimated $283K sold.

Michael Gelband first reported a position in ALDX in Q2 2020 and held it in 15 quarters. The position peaked at $1.86M in Q1 2021. 108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Michael Gelband reported no remaining Aldeyra Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 167,604 Aldeyra Therapeutics shares in Q2 2026, an estimated $283K.
  • Michael Gelband first reported a position in Aldeyra Therapeutics in Q2 2020 and held it in 15 quarters.
  • Michael Gelband's Aldeyra Therapeutics position peaked at $1.86M in Q1 2021.
  • 108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.